Supply of the medicinal product Blinatumomab
About This Opportunity
This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Russia, Europe, this opportunity is open to firms and consortiums, with an estimated budget of RUB 686,714. Proposals must be submitted before June 28, 2026.
Published through GosPlaN Russia, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.
Description
Original language: RussianThis tender, originating from Russia and managed through the state procurement system (gosplan_ru), concerns the supply of the medicinal product Blinatumomab. Blinatumomab is a bispecific T-cell engager immunotherapy used in the treatment of certain types of acute lymphoblastic leukemia (ALL). The procurement aims to secure a supply of this critical therapeutic agent for use within the Russian healthcare sector. As a state procurement, it is expected that bidders must meet rigorous quality and regulatory requirements, including adherence to pharmaceutical Good Manufacturing Practice (GMP) and all applicable Russian Federation laws governing medicinal products. Potential suppliers should be authorized distributors or manufacturers with the capacity to deliver the specified drug in its approved formulations. The tender documentation will likely detail the required quantities, specifications, packaging, delivery schedules, and any specific storage and handling instructions necessary for maintaining the drug's efficacy. Compliance with national drug registration and pharmacovigilance requirements will also be essential.
This procurement is crucial for providing advanced oncological treatments to patients in Russia.
Data provenance
This notice is sourced from GosPlaN Russia and was originally published on June 18, 2026. Last refreshed today. Original language: Russian. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About 2723166322
2723166322 has issued 130 procurement notices on BidsFactory, including 9 currently open and 0 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Agriculture & Food Security. All notices are published for Russia. Notices are distributed via GosPlaN Russia. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Who is the contracting authority?
This notice was issued by 2723166322 in Russia. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is RUB 686,714 - RUB 686,714. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Russia. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit GosPlaN Russia to access the full notice, required documents, and submission instructions provided by the contracting authority.
When does this tender close?
The submission deadline is June 28, 2026. You have 3 days left to prepare and submit your proposal to the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.